Aarey Drugs & Pharmaceuticals

quarterly
yearly
ParticularsSep '21Dec '21Mar '22Jun '22Sep '22
Revenue134.65140.27120.25117.3476.26
Expenses131.73137.71118.97118.3572.40
EBITDA2.922.561.28-1.013.86
EBIT2.422.060.69-1.423.44
Profit Before Tax3.122.201.980.802.32
Net Profit2.841.95-0.760.802.12
Financial Ratios
Operating Profit Margin2.17%1.83%1.06%-0.86%5.06%
Net Profit Margin2.11%1.39%-0.63%0.68%2.78%
Earning Per Share (Diluted)1.220.77-0.370.320.83
Dividends Per ShareNANANANANA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.5.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI